PRISM MediaWire

Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential

NEW YORK and SANTA BARBARA, Calif., July 30, 2024 - PRISM MediaWire - Phytanix Bio, a pioneering preclinical stage pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules, today announced the release of its...

30 July 2024

Artificial Intelligence:

AI Datacenters and Infrastructure May Be the Next AI Related Play. Here’s Where to Look

New York, July 24, 2024 - PRISM MarketView - As artificial intelligence (AI) continues to grow in significance, the infrastructure supporting AI technologies has also evolved. This also opens a new door for opportunities related to AI as investors look to boost portfolio...

24 July 2024

BioStem Receives Institutional Review Board (IRB) Approval to Advance a Clinical Study Evaluating AmnioWrap2™ in Diabetic Foot Ulcers

POMPANO BEACH, FL, July 10, 2024 - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the IRB has approved a ...

10 July 2024

Digital Utilities Ventures Completes Feed Earth Now Merger - Accelerates Growth of Regenerative Agriculture Movement

MANKATO, MN, May 16, 2024 – PRISM MediaWire - Digital Utilities Ventures, Inc. (OTC Pink: DUTV) is pleased to announce the successful acquisition of Feed Earth Now, LLC. The consummation of this transaction is a significant step forward in DUTV's mission to leverage inn...

16 May 2024

SIPP Industries Announces Strategic Acquisition of Revenue Share in Calypso Pharmaceuticals to Bolster Position in Cannabis and Hemp Industries

COSTA MESA, CA, May 1, 2024 – PRISM MediaWire - Sipp Industries, Inc. (OTC: SIPC), a leading player in the cannabis and hemp industries, announces its strategic acquisition of revenue share in Calypso Pharmaceuticals, a Texas-based company renowned for its innovative pro...

1 May 2024

World Glaucoma Day – March 12, 2024

New York, March 12, 2024 - PRISM MediaWire - World Glaucoma Day is observed every year on March 12th to raise awareness about glaucoma, a serious eye disease that can lead to irreversible vision loss if not diagnosed and treated in a timely manner. Glaucoma affects milli...

12 March 2024

Understanding Autism Spectrum Disorder in Children: Insights and Advances in Treatment

New York, March 08, 2024 - PRISM MediaWire - Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by challenges in social interaction, communication, and repetitive behaviors. It affects individuals differently and can range from mild to...

8 March 2024

Food and FoodTech

Brewing Excellence: A Deep Dive into Black Rifle Coffee's Rise in the Coffee Industry

New York, March 07, 2024 - PRISM MediaWire - In the ever-evolving landscape of the coffee industry, one brand has captured the attention of consumers and aficionados alike with its bold flavors, unapologetic branding, and unwavering commitment to veterans' causes. Black ...

7 March 2024

Medical Devices

Nexalin Tackles Sleepless Nights with Innovative Insomnia Device

New York, March 07, 2024 - PRISM MediaWire - In a world where stress and anxiety have become prevalent, sleep disorders like insomnia have emerged as significant health concerns affecting millions of individuals globally. Sleeplessness not only impacts one's physical wel...

7 March 2024

Medical Devices

Neuronetics Announces Substantial Growth in 2023, Enhances Accessibility to Neurohealth Therapy; Stock Prices Surge by 23%

New York, March 06, 2024 - PRISM MediaWire - Neuronetics, Inc. (NASDAQ: STIM), a prominent medical technology firm focused on neurohealth therapies, disclosed notable financial and operational milestones for the fourth quarter and full-year of 2023. The company has achie...

6 March 2024